Embolization Coil Market to grow by USD 481.9 million from 2022 to 2027, Abbott Laboratories and Achieva Medical are among the key companies -Technavio
NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The embolization coil market is estimated to grow by USD 481.9 million from 2022 to 2027 at a CAGR of 5.69% according to Technavio. The market is segmented by application (neurology, oncology, peripheral vascular disease, cardiology, and others), type (detachable coil and pushable coil), and geography (North America, Europe, Asia, and the Rest Of World (ROW)).
Abbott Laboratories, Achieva Medical, BALT Group, Boston Scientific Corp., Braile Biomedica, Cardinal Health Inc., Cook Medical LLC, Grand Pharmaceutical Group Ltd., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merit Medical Systems Inc., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Shape Memory Medical Inc., Sirtex Medical Pty Ltd., Stryker Corp., and Terumo Medical Corp. are key companies.
Abbott Laboratories - The company offers an embolization coil and related products such as Amplatzer Vascular Plug II.
BALT Group - The company offers embolization coils such as OptiMAX.
Boston Scientific Corp.- The company offers embolization coils such as Interlock and IDC Detachable Embolization Coils.
The availability of favorable reimbursement coverage is a key factor driving growth. In developed regions like North America and Europe, reimbursement for embolization coils is influenced by public or private payment systems. Governments are promoting their use through initiatives and favorable policies. In the US, Medicare and Medicaid cover procedures under DRG and APC payments, while CPT codes reimburse physicians. Emerging countries like China and India are also adopting reimbursement policies, leading to increased demand for advanced embolization coils.
- Technological advances and innovations are the primary trends shaping the growth.
- Complications associated with the use of embolization coils are one of the major challenges impeding growth.
Drivers, Trends, and Challenges have an impact on dynamics and can impact businesses. Find some insights from a free sample report!
Why Buy?
- Add credibility to strategy
- Analyzes competitor's offerings
- Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Embolization Coil Market report?
- CAGR during the forecast period
- Detailed information on factors that will drive the growth between 2023 and 2027
- Precise estimation of the size and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the Embolization Coil industry across North America, Europe, Asia, and the Rest of the World (ROW)
- A thorough analysis of the competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of Embolization Coil companies
Technavio's SUBSCRIPTION platform
Embolization Coil Market: Overview
Embolization coils are crucial medical devices used in interventional radiology and endovascular procedures for vascular embolization. These coils are designed to block blood flow in specific vessels, often used in the treatment of aneurysms and other vascular disorders. The procedure, known as coil embolization, is a minimally invasive technique that offers advantages over traditional surgical methods. Radiopaque coils enable visualization during medical imaging, aiding in precise placement and monitoring. This technology is a key component of interventional cardiology and neurointerventional radiology, contributing to advancements in medical imaging and healthcare innovation. Embolization coils are part of a range of therapeutic devices used in arterial embolization, providing effective treatment options for various medical interventions in vascular medicine.
Related Reports
The Neuroendovascular Non-coils Market size is estimated to grow by USD 329.15 million at a CAGR of 4.29% between 2023 and 2028.
The global flow diversion aneurysm treatment market size is estimated to grow by USD 2,107.08 million at a CAGR of 8.8% between 2022 and 2027.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Sizes
Five Forces Analysis
Segmentation by Application
Segmentation by Type
Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential areas and assess their competitive positions within changing scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article